paediatrics Brussels 17

CCG/RTOG

• 233 pts randomized to 35-40 Gy CSRT, 50-55 Gy PFRT +/- VCR, CCNU, prednisone x 1 year • No difference in survival • Benefit in those receiving chemotherapy with T3, T4 or M+ disease

Evans AE et al. J Neurosurg 1990; 72:572-82